IB Net Payout Yields Model

Huge Patent Potential With Spherix


With patent stocks being all the rage in 2012, the recent deal for Spherix (SPEX) to purchase a bunch of patents created by the Harris Corporation has basically gone unnoticed. Possibly because the company was mostly unknown prior to this pending deal or possibly the leading patent stocks of VirnetX Holding (VHC) and Vringo (VRNG) have struggled this year thereby lessening investor appetite. The recent news on quickly closing another patent deal with Rockstar has again jumpstarted the stock after the original news had faded sending the stock to new lows.

Spherix is in the process of launching a broad IP monetization initiative adding to its drug development and patenting expertise. The company has identified a couple of undervalued IP assets that it plans to generate value for shareholders through licensing and enforcement.

Read the full article at Seeking Alpha.


Disclosure: No positions mentioned. Please review the disclaimer page for more details. 



Comments

Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

C3.ai: Trough Quarter

C3.ai: Out Of Steam (Rating Downgrade)